Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Resolian Names New CEO | Contract Pharma
Breaking News, Promotions & Moves

Resolian Names New CEO

Rob Stachlewitz joins Resolian as CEO, while current CEO Pat Bennett transitions into the role of Chief Business Officer and President of Scientific Affairs.

Resolian, a global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, has announced leadership changes as the company expands its global footprint and operational capabilities.
 
Rob Stachlewitz will join Resolian as Chief Executive Officer (CEO), while current CEO Pat Bennett will transition into the newly created role of Chief Business Officer and President of Scientific Affairs.

CEO Transition

Incoming CEO Rob Stachlewitz joins Resolian with an impressive track record, having most recently served as Corporate Vice President and General Manager at Charles River, where he oversaw their largest site.
 
Stachlewitz brings 15 years of pharmaceutical R&D experience, having held key roles at Boehringer Ingelheim, Abbott Laboratories, and Procter & Gamble. As CEO, Stachlewitz will guide Resolian through its next phase of strategic growth, enhancing its operational capabilities and global presence.
 
Meanwhile, as Chief Business Officer and President of Scientific Affairs, Pat Bennett will focus on growing new service capabilities and enhancing customer relationships, leveraging his 30+ years of experience in bioanalytical sciences and business development. Bennett will also oversee several critical functions to foster client collaboration and synergies across the Resolian team.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters